Hematologic Oncology Update
Hematologic Oncology Update
✓

Chronic Lymphocytic Leukemia — Microlearning Activity 1

· Pokaż notatki
00:24:32
Podcasts
RSS
Link

O TYM ODCINKU

Featuring perspectives from Dr Catherine C Coombs, including the following topics:

  • Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00)
  • Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor therapy in CLL; minimal residual disease and disease monitoring (4:10)
  • Ongoing Phase III trials of BTK inhibitor/B-cell lymphoma 2 inhibitor combinations in previously untreated CLL (10:05)
  • Pirtobrutinib as first-line therapy for CLL and long-term safety data (15:22)

CME information and select publications

Nauka
Medycyna
Język angielski
Stany Zjednoczone
UżyjAPI, aby pobrać ten odcinek wJSON

POKAŻ NOTATKI 🔗

00:00:00Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL)
00:04:10Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor therapy in CLL; minimal residual disease and disease monitoring
00:10:05Ongoing Phase III trials of BTK inhibitor/B-cell lymphoma 2 inhibitor combinations in previously untreated CLL
00:15:22Pirtobrutinib as first-line therapy for CLL and long-term safety data

TRANSKRYPCJA 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki Hematologic Oncology Update.
Umieść ten pasek wyszukiwania w swojej witrynie

INNE ODCINKI W TYM PODCASCIE

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network

Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00) First-Line Treatment (1:33) Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy (20:36) CME information and select publications
00:50:22
UDOSTĘPNIJ
ZAPISZ
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics: Introduction (0:00) New and Emerging Strategies with Bispecific Antibodies in Multiple Myeloma (MM) — Dr Raje (2:20) Utility …
00:59:31
UDOSTĘPNIJ
ZAPISZ
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies

Featuring an interview with Dr L Elizabeth Budde, including the following topics: Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus combination therapy (0:00) Management of BsAb-induced cytokine release syndrome and other toxicities (7:35) Use of BsAbs in the f…
00:47:06
UDOSTĘPNIJ
ZAPISZ
Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management

Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: Introduction (0:00) Minimal Residual Disease Assays in Community-Based Practice (1:24) New Developments in Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Davids (8:12) Richter T…
00:58:15
UDOSTĘPNIJ
ZAPISZ
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Dr. Neil Love, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

REKOMENDACJE
Skorzystaj z API aby pobrać ten odcinek